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Abstract:
Estrogen replacement therapy appears to delay the onset of Alzheimer's disease
(AD). The mechanism whereby estrogen prevents the pathogenesis of AD is unknown. In
the present study, I examined the effects of 17-~-estradiol (E2) on neurite outgrowth from
adult mice cortical neurons (AMC) in culture. I found that E2 increases apoE secretion
and neurite outgrowth in AMC neurons from wild type mice in a dose dependent fashion.
The neurite outgrowth promoting effect of E2 was not observed in AMC neurons derived
from age-, sex-, and stain-matched apoE deficient/apoE gene knockout (apoE KO) mice.
Furthermore, E2 has isoform specific effects on neurite outgrowth in the presence of
purified recombinant human apoE. The presence of human apoE2 or apoE3 greatly
augmented E2 effects on promoting neurite outgrowth, whereas the presence of apoE4
had no significant effect. Consistent with these findings, E2 had differential effects on
neurite outgrowth from AMC neurons derived from transgenic mice expressing human
apoE isoforms. Incubation of AMC neurons from apoE3 transgenic mice with E2
significantly increased neurite outgrowth, whereas incubation of AMC neurons from
apoE4 transgenic mice with E2 had no significant effect. In summary, my data suggest
that apoE isoforms play a critical role in mediating the neurite outgrowth promoting
effect of E2.

1. Introduction:
Alzheimer's Disease (AD) is an irreversible, progressive brain disorder that
occurs gradually and results in memory loss, unusual behavior, personality changes, and
a decline in thinking ability. AD is the major form of dementia, and is characterized by
senile plaques and neurofibrillary tangles in the brain and loss of cholinergic neurons in
the basal forebrain (Gooch and Stennett, 1996). The senile plaques in the brains of AD
patients consist of amyloid deposits surrounded by dystrophic axons. The amyloid is
referred to as

~-amyloid (A~),

which is a product of inappropriate cleavage from the

amyloid precursor protein (APP) (Haass and Selkoe, 1993; Gooch and Stennett, 1996;
Vassar et al., 1999).

The second major type of brain lesion in AD patients, the

neurofibrillary tangles, are located in cell bodies and apical dendrites.

The tangles

contain paired helical filaments composed of abnormally phosphorylated tau proteins.
Tau is one of the microtubule-associated proteins (MAPs) that stabilizes microtubules
against disassembly and provides a mechanism for them to interact with other cell
components (Gooch and Stennett, 1996).
Apolipoprotein E (apoE) is a 299 amino acid component of lipoproteins with a
molecular weight of 37-kDa that mediates endocytotic lipid uptake by cells via several
lipoprotein receptors. ApoE plays a vital role in the regulation of lipoprotein metabolism
and in the control of lipid transport and lipid redistribution among target tissues and cells
(Mahley, 1988; Weisgraber, 1994). Lipid transport and redistribution is regulated by
apoE via interaction with lipoprotein receptors (Mahley, 1988). Cellular uptake and
degradation of the lipoproteins is initiated by receptor-lipoprotein binding. The lipid
becomes available for utilization in the regulation of intracellular cholesterol metabolism.
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ApoE, therefore, serves as a ligand for the receptor-mediated clearance of lipoproteins
from the plasma (Rall et al., 1982).
ApoE is encoded by a single polymorphic gene, which contains four exons on
chromosome 19 in humans (Mahley, 1988; Rall et al., 1982; Das et al., 1985; Paik et al.,
1985).

The three major allele isoforms for the apoE gene are e2, e3, and e4, the

frequencies of these three alleles in the general population are 8%, 77%, and 15%,
respectively (Gooch and Stennet., 1996; Mahley 1994). The molecular basis of this
polymorphism of the apoE gene results from cysteine-arginine interchanges at two
positions in the apoE protein (Weisgraber, 1994). These single amino acid substitutions
are found at residues 112 and 158 (Rall et al., 1982). The most common isoform, apoE3,
contains cysteine at residue 112 and arginine at position 158. ApoE2 has cysteine at both
positions and apoE4 contains arginine at both positions (Weisgraber, 1994). Recent
studies have demonstrated that inheritance of the e4 allele of apoE increases the risk of
Alzheimer's disease (AD) and that the inheritance of the e2 allele decreases the risk
(Gooch and Stennet., 1996).
It is believed apoE functions as a lipid carrier molecule in membrane remodeling

in the response to peripheral and central nerve damage, possibly to scavenge cholesterol
from cellular debris for use in axonal regeneration and remyelination (Ignatius et al.,
1986; Mahley, 1988; Poirier, 1996). In humans the brain is second only to the liver in
apoE production (Beffert et al., 1998; Elshourbagy et al., 1985). Transcripts for apoE are
distributed throughout all regions of the brain, and have been localized to astrocytes and
microglia by in situ hybridization.

In the central nervous system (CNS), apoE is

synthesized and secreted primarily by glial cells (astrocytes, microglia and to a lesser
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extent, by macrophages) (Elshourbagy et al., 1985; Pitas et al., 1987) but not by neurons.
ApoE serves as a ligand for the low-density lipoprotein receptor (LDLR) in primary
cultures of rat brain astrocytes (Beffert et al., 1998).

In cerebrospinal fluid, apoE is

found associated with high-density lipoprotein (HDL) particles and appear to play a
major role in lipid transport in the CNS. Previous studies have shown that apoE plays a
pivotal role in maintaining central nervous system function and synaptic plasticity,
especially after neuronal damage. ApoE levels dramatically increase after brain injury
(Boyles et al., 1990; Boyles et al., 1989; Ignatius et al., 1986; Leblanc et at., 1990) .
Increased apoE immunoreactivity is present in the brains of patients with such
neurological disorders as Down's syndrome, Creutzfeld-Jacob disease, and Alzheimer's
disease (AD) (Namba et al., 1991). It has been demonstrated that expression of apoE
increases following optic nerve injury, but absolute levels of apoE do not increase
(Ignatius et al., 1986). ApoE mRNA is increased in the brains of AD patients and in the
response to injury in both CNS (Boyles et al., 1989) and peripheral nerve system (Snipes
et al., 1986).

In culture from fetal dorsal root ganglion cultures, incubation with P-very lowdensity lipoprotein CP-VLDL) particles, which are rich in both apoE and cholesterol,
showed increased neurite outgrowth and branching (Handelmann et al., 1992). These
results have been the basis for proposing that apoE-containing lipoproteins are involved
in the mobilization and redistribution of lipids in the repair and maintenance of myelin
and axonal membrane following peripheral nerve injury (Beffert et al., 1998). Based on
these observations, it has also been proposed that apoE is involved in neurodegenerative
processes by isofom1-specific effects on cytoskeletal stability and neurite outgrowth
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(Mahley et.al.. 1994; Weisgraber and Mahley, 1996). In vitro studies with dorsal root
aanalion neurons have shown that addition of apoE3 to a culture stimulated neurite

~

~

outgrowth whereas apoE4 decreased neurite extension (Nathan et al.. 1994).

Fom1er

studies from our laboratory have shown that addition of apoE3 to adult mouse cortical
neuron cultures significantly increased neurite outgrowth. These data imply that apoE is
important for peripheral nerve regeneration (Mahley, 1988). The data from apoE
knockout (apoE KO) mice, however, does not support this hypothesis. Regeneration of
nerves in both control mice and apoE KO mice were morphologically identical at two and
four weeks following sciatic nerve crush (Popko et al., 1993; Goodrum, 1995). This
suggests that other apolipoproteins in the PNS may substitute for apoE when it is absent.
Therefore, the specific role of apoE and its importance in the PNS remains unclear.
There are three forms of AD: early-onset familial AD, late-onset familial AD and
sporadic AD. Early-onset familial AD, which accounts for only 5% of human patients,
has been found to be related to mutations on chromosomes 1, 14, and 21 (Gooch and
Stennett, 1996).

The late-onset familial AD and sporadic AD, which accounts for

approximately 95% of all late-onset AD cases, are associated with the inheritance of e4
(Poirier et al., 1993; Beffert et al., 1998). About 80% of familial and 64% of sporadic
late-onset AD cases carry at least one copy of the e4 allele compared to 31 % of controls
(Corder et al., 1993; Beffert et al., 1998). Furthermore, the e4 allele also has a strong
impact on the age of onset of clinical symptoms in AD. Studies have shown that the
average age at onset of AD patients without the e4 allele is 84.3 years, compared to 75.5
years with individuals with a single e4 allele, and 68.4 years in individuals with two
copies of e4. Most importantly, the survival time also decreases with an increasing gene
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dose of apoE4 (Corder et al., 1993, Gooch and Stennett, 1996). These studies have been
confirmed by many laboratories worldwide, and are now universally accepted that the
apoE genotype is the major risk factor for AD. Unfortunately the mechanism whereby
apoE4 leads to the pathogenesis of AD is unknown.
In addition to apoE genotype, it seems that estrogen plays an important protective
role in the development of AD. Estrogen is a hormone dominant in the female
reproductive system. Estrogen can improve blood circulation in the brain as well as
stimulate nerve cell growth. It has also been shown to increase levels of acetylcholine,
and it impedes the deposition of amyloid (Inestrosa et al., 1998). Women are statistically
more susceptible to AD which leads researchers to believe that hormones may also play a
crucial role in the disease process. A plausible explanation for the increased occurrence
of AD in women is due to the loss of ovarian steroids in the menopause stage. The
normal age of menopause is 54 years and the average life span of women is 78 years.
This indicates that most women spend almost one-third of their life in an estrogendeprived state.

There is recent evidence that postmenopausal estrogen replacement

therapy (ERT) is inversely correlated, both in dose and duration of therapy, with the
incidence of AD (Phillips et al., 1992). Preliminary trials indicate a positive effect of
ERT on cognition in both cognitively impaired and normal postmenopausal women
(Sherwin 1988).

Additional studies have shown that estrogen serves a normal

maintenance role in the same regions of the brain that are most effected in AD. Estrogen
treatment in experimental animals promotes recovery from neurological damage.
Estrogen administration increases glial cell markers and apoE in most of these animal
models (Simpkins et al., 1994).
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Recently studies have suggested that estrogen's protective effects are through its
action as a trophic factor for cholinergic neurons, a modulator for the expression of apoE
in the brain, an antioxidant compound decreasing the neuronal damage caused by
oxidative stress (Inestrosa et al., 1998). In mixed glial cultures that contain both
astrocytes and microglia,

17-~-estradiol

(E2) treatment induced two-fold increases in

apoE mRNA over untreated controls and the largest increase is seen at an estrogen
concentration of 0.1 nM, corresponding to physiological levels of circulating estrogen
during proestrus (0.05 nM) and pregnancy (0.5 nM) (Stone et al., 1997). Previous studies
have shown that estrogen treatment significantly increased the neurite outgrowth of
acetylcholinesterase-positive fibers from embryonic basal-forebrain tissues transplanted
into the anterior chamber of the eye (Honjo et al., 1992), indicating that estrogen may
have a direct trophic effect upon basal-forebrain cholinergic neurons. The cholinergic
neurons located in the basal forebrain are particulary susceptible to degeneration in AD
and have been correlated in age and disease-related cognitive decline (Whitehouse et al.,
1981). These results indicate that estrogen could have positive effects on memory and
learning processes (Gibbs 1997).
The way in which estrogen interacts with apoE and neurons is not completely
known.

The mechanism for this process would prove to be quite important for

developing novel therapies for Alzheimer's disease. The primary aim of my study was to
determine the pathway by which 17-~-estradiol (E2) increases neurite outgrowth from
AMC neurons. In this thesis, I demonstrate the following specific questions: 1) E2 effect
on apoE secretion and neurite outgrowth in AMC neurons from wild type mice. 2) E.2
effect on neurite outgrovvth in A.1'1C neurons derived from age-, sex-, and stain-matched
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apoE deficient/apoE gene knockout (apoE KO) mice. 3) Does E2 have isoform specific
effects on neurite outgrowth in the presence of purified recombinant human apoE? 4) E2
effect on neurite outgrowth from Alv1C neurons derived from transgenic mice expressing
human apoE isoforms.
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2. lVIaterials and lVIethods
2.1. lVIaterials
2.1.1. Adult mouse cortical culture
Transgenic human apoE3, transgenic human apoE4 mice, homozygous apoE KO
mice (C57BL/6-Apoe<tmiUnc>, Cat. # 002052) bred 10 generations onto the C57BL/6
background and control mice (C57BL/6, Cat. # 000664) were obtained from Jackson
Laboratory (Bar Harbor, MA). Cell culture medium, including Hibernate A (Cat.# 10740025), Neurobasal (Cat. # 21103-049), and B27 medium supplement (Cat. # 17504-010)
were purchased from Life Technologies Inc., (Gaithersburg, MD). Glutamine (Cat. # G3126) and poly-D-lysine (Cat. # P-6407) were purchased from Sigma Chemicals (St.
Louis, MO). Papain (Cat. # 3119) was obtained from Worthington (Lakewood, NJ).
Gentamicin (Cat. # 15710-015), FGF2 (Cat. # 13256-029), and Optiprep (Cat. # 1030061) were from Life Technologies Inc., (Gaithersburg, MD). Glass cover slips (Cat. #
P7-63-3029) were purchased from Carolina Biological (Burlington, NC). Falcon Brand 35
mm diameter dishes (Cat. # 08-772-4A), Costar Brand Tissue Culture 24-well plates (Cat.
# 07-200-84), 50 ml tube (Cat. # 05-539-6), 15 ml centrifuge tubes (Cat.# 05-539-5), and
9-inch pipettes (Cat.# 13-678-6B) were purchased from Fisher Scientific (Chicago, IL).

2.1.2. Neurite outgrowth assay
Human recombinant apoE3 (Cat. # P2003) and apoE4 (Cat. # P2004) were
purchased from Panvera (Madison, WI), and dialyzed overnight in O. lM ammonium
bicarbonate.

17-~-estradiol

(Cat. # E-3229) was purchased from Sigma (St. Louis, MO)

and was dissolved in 95% ethanol.

2.1.3. ApoE quantification
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The monoclonal anti-apoE (3Hl) used for immunoprecipitation was obtained from
the University of Ottawa, Heart Institute. HRP conjugated secondary antibody, and rabbit
anti-goat IgG (Cat.# AP106P) Yvas obtained from Chemicon (Temecula, CA). Protein ASepharose CL-4B (Cat. # P-3391) and BSA (Cat. # A-9418) were obtained from Sigma
Chemicals (St. Louis, MO). Goat anti-human apoE (Cat. # 178479) was purchased from
Calbiochem (San Diego, CA). All other materials used for apoE quantification, including
pre-cast 4-20% gradient gels (Cat. # FB3435), Millipore Irnmobilon-P Transfer
Membranes (Cat. #IPVHOOOlO), Pierce SuperSignal West Pico Chemiluminescent
Substrate (Cat. # PI34080), Kodak BioMax Light-2 film (5*7', Cat. #05-728-53), Tris
(Cat. #BP154-1) , Glycine (Cat.# BP381-l), SDS (Cat.# BP166-100), Tween 20 (Cat.#
BP337-500) and sodium bromophenol blue (Cat. # BP-114-25) were purchased from
Fisher Scientific (Chicago, IL).

2.1. 4. Immunocytochemist1y
The mouse anti-neurofilament-70 (Cat. #N-5388), mouse anti-Glial Fibrillary
Acidic Protein (GF AP) (Cat. # N-3893), and FITC-conjugated lectin from Bandeiraea

simplicifolia (BSL-1) were obtained from Sigma Chemicals (St. Louis, MO). The FITCconjugated goat anti-mouse IgG-Fab 2 specific (Cat. # 115-095-006) and normal goat
serum (Cat.# 005-000-121)were purchased from Jackson IrnmunoResearch (West Grove,
PA). Paraformaldehyde (Cat. # 04042-500) was purchased from Fisher Scientific (St.
Louis, MO). Triton X-100 (Cat. #T-9284), n-propyl gallate(Cat. # P-3130), and glycerol
(Cat. # G-6279) were purchased from Sigma Chemicals (St. Louis, MO).
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2.2. lVlethods
2. 2.1 Adult mouse cortical neuronal culture

For each experiment, a single female, 4 month old mouse was anesthetized with
sodium pentobarbital (80 mg/kg). The entire cerebral cortex was dissected from the rest of
the brain in 2 ml B27/Hibernate A medium [B27/Hibernate A with 0.5 mM glutamine] in
a 35 mm diameter Petri dish placed at 4°C. The cortex was sliced (0.5 mm thickness) and
transferred to a 50 ml tube containing 5 ml B27/Hibernate A medium. After warming for 8
min at 30°C, slices were digested with 6 ml of a 2 mg/ml papain solution in Hibernate A
for 30 min at 30°C in a gyrating water bath to keep the slices suspended. Slices were
transferred to 2 ml B27/Hibernate A medium in a 15 ml tube. After 2 min at room
temperature, slices were triturated 10 times with a siliconized 9-inch Pasteur pipette, and
allowed to settle for 1 min. Approximately 2 ml of the supernatant was transferred to
another tube, and the sediment resuspended in 2 ml B27/Hibernate A medium. The above
step was repeated twice, and a total of 6 ml collected. The resultant supernatant was
subjected to density gradient centrifugation at 800g for 15 min. The density gradient was
prepared in four 1 ml steps of 35, 25, 20 and 15% Optiprep in B27/Hibernate A medium
(v/v). The brain fraction containing the neurons was collected, and diluted in 5 ml
B27 /Hibernate A medium. After centrifuging twice at 200g for 2 min, the cell pellets were
resuspended in 3 ml B27/Neurobasal A medium [B27/Neurobasal A with 0.5 mM
glutamine, no glutamate, 0.01 mg/ml gentamicin]. The cells in the suspension were
counted in a hemacytometer, and 40,000 cells were plated in 50 µl aliquots on glass cover
slips (12 mm diameter) previously coated overnight with 100 µI of 50 µg/ml poly-Dlysine in water. Following 1 hr incubation in a humidified incubator at 37 °C and 5% C0 2 ,
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cover snps were transterred to a 24-well plate containing 0.4 ml B27/Neurobasal A

medium. Cover slips were rinsed twice with B27 /Hibemate A medium, and then 0.4 ml
growth medium [B27 /Neurobasal A medium with 5 ng/ml FGF2] was added to each well
and the plate was further incubated. Neurite outgrowth, and viability assays were
performed after 4 days of incubation, as described below. For culture periods greater than
4 days, half of the medium was replaced with B27/Neurobasal A with 10 ng/ml FGF2
every four days.
2.2.2. Neurite Outgrowth Assay
To assess neurite outgrowth, neurons were grown in growth medium (GM) alone
or with other test reagents (E2, 5µg/ml human-apoE, etc). Following 3 days of incubation,
the length of the longest neurite (neurite extension) and total length of neurites (combined
length) of each neuron were measured using an inverted phase-contrast microscope. For
each experiment, a minimum of 50 neurons were measured for each treatment condition.
In experiments that involved the effects of estrogen and human apoE isoforms on
neurite outgrowth, neurons from adult mice were prepared as described above. After 24
hours incubation, human apoE isoforms or various concentrations of estrogen were added
directly to the medium and continued incubating for another 48 hours. On the third day of
culture, neurite outgrowth was quantified as described.
2.2.3. ApoE quantification
Two ml of medium from three-day-old cultures were collected and centrifuged to
eliminate suspended cells. ApoE was imrnunoprecipated by incubating the medium with 2
µg of monoclonal anti-apoE (3Hl) on ice for 1 hr. Following incubation, 50 µl of 10%
Protein A-Sepharose CL-4B was added, and the medium was further incubated on ice for·
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1 hr on a shaker. The medium vvas centrifuged at 10,000g for 15 min at 4 °C, and the
supernatant discarded. The pellet was boiled for 5 min in 2X Lammeli sample buffer and
electrophoresed on 4-20% SDS-polyacrylamide gradient gels in an EC120 Mini gel
vertical system. The samples were run at 80 V until separation began, and then at 140 V
until the dye front neared the bottom of the gel (Bellosta et. al., 1995).
Following electrophoresis, the gel was placed in transfer buffer (3.03 g Tris-base,
14.4 g glycine, 200 ml methanol, 800 ml dH 20) on a shaker for 10 min. The transfer
membrane, Millipore Irnmobilon-P Transfer Membrane, was first soaked in methanol for
5 sec then washed in dH2 0 for 5 min to remove excess methanol. The proteins in the gel

were transferred to the Irnmobilon-P membrane using a Bio-Rad Trans-blot Transfer Cell
following manufacturer's protocol.
Blots were washed twice (5 min each) with TBST buffer [TBS buffer with 0.05%
Tween 20]. Blots were then incubated in goat anti-human apoE (1:5,000 dilution in TBST
buffer) for 1 hour on a shaker at room temperature. The membrane was then washed 4
times (10 min each) in TBST buffer. Blots were incubated in HRP-conjugated rabbit antigoat IgG (1:10,000 dilution in TBST buffer) for 1 hr on a shaker at room temperature,
washed 5 times (10 min each) with TBST buffer, incubated with Pierce SuperSignal West
Pico Chemiluminescent Substrate, and then exposed to Kodak BioMax Light-2 film. A 35
kDa band was visualized which is consistent with the published molecular weight of apoE.
Bands were quantified by densitometry (Scion Image).
2. 2. 4. Immunocytochemistry

Cells from 4-day old cultures were rinsed with warm PBS (3TC) and fixed with
4% paraformaldehyde in PBS for 20 min at room temperature. After rinsing twice with
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PBS, cells were permeabilized with 0.5% Triton X-100 in PBS for 5 mm. Cells were
rinsed again with PBS, and then blocked with blocking solution [5% normal goat serum,
0.05% Triton X-100 in PBS] for l hr. Cells were incubated overnight at 4'C with mouse
anti-neurofilament 200 (1:40), or mouse anti-GFAP (1:1,200) in the blocking solution.
After rinsing four times with PBS, cells were incubated with FITC-conjugated goat antimouse IgG-Fab2 (1:200) in blocking solution for 60 min. Cells were washed four times in
PBS, slips were mounted in anti-photobleach medium (0.85 M n-propyl gallate, 60%
glycerol in TBS). Immunoreactive cells were counted and photographed on an Olympus

BXSO microscope with appropriate fluorescence excitation filters. Controls without
primary antibody were negative.
For-BSLl labeling of microglia, cells were fixed as described above, rinsed with
warm PBS, and incubated with fluorescein conjugated BSLl (1:100 dilution) for 15 min at
room temperature. Following incubation the cells were rinsed with PBS, and fixed with
4% paraformaldehyde in PBS for 5 min. After rinsing in PBS, slips were mounted and
photographed as described above.

2.2.5 Statistical Analysis
All experiments were repeated four times using different preparations of adult
mouse cortical neurons, and reagents. The data in individual experiments were presented
as the mean ± standard error, and statistical analysis (unpaired, two tailed t-test) was
performed using Statview software.
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3. Results:
3.1. Characterization of adult mouse cortical neuronal culture

I modified techniques for the in vitro culture of neurons from adult mice as
prev10us described (Brewer, 1997). The total recovery of viable cells after 3 days in
culture averaged 65-70% of the cells plated. Fig.

1 shows the results for

immunofluorescent labeling of cell types in the culture. The majority of the cells in culture
were neurofilament positive, representing - 70% of the cells (Fig. lA). GFAP positive
cells comprised an average of 13%, while BSLl stained cells represented about 14% of
the total cells in culture. These three markers identified an average of 97% of the viable
cells present in a three-day old culture. Representative morphologies of immunostained
cells are shown in Fig. lB. Neurofilament 200 immunoreactive cells displayed several
long processes· with branches. GFAP positive cells had a smaller number of processes with
fewer branches. Microglial cells were flat and round with very few short processes. The
concentration of apoE in the medium of a 3-day-old WT culture, as determined by
quantitative immunoblotting, was 25-37 ng/ml. Medium from apoE KO culture had no
detectable apoE.
3.2. Effects of E2 on neurite outgrowth from adult mouse cortical neurons derived from wide
type mice

Cultures of AMC neurons from wild type mice were treated with 0.1 pM, 1.0 pM,
0.1 nM, 1.0 nM .and 10 nM of E2, and neurite extension and combined length of neurites
in cultures were quantified. E2 concentrations were added at 24 hours and neurite
outgrowth was monitored at 72 hours. AMC neurons treated 1 pM, 0.1 nM and 1 nM E2
had significantly longer (p<O. 01) neurite extension and combined length as compared to
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Fig. 2A. Effects of E2 on Neurite Outgrowth from Adult
Mouse Cortical Neurons. Phase contrast photographs of
representation neurons from wide type mice was incubated
for 3 days in medium alone and in medium containing
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neurons grown in medium alone (Fig. 2.).

3. 3 Ejfects of £2 on apoE secretion from adult mouse cortical neurons derived from ivide
t_vpe mice
AMC cultures from wild type mice were incubated with varying concentration of
estrogen as described above. The secreted apoE in the medium was quantified by
immunoprecipitation followed by immunoblotting. MIC cultures treated with 1.0 pM, 0.1

nM and 1.0 nM E2 secreted significantly more apoE concentration (p<0.01) than that in
culture grown in medium alone (Fig. 3.).

3. 4. Time course of £2 on apoE secretion from adult mouse cortical neurons
The time course of apoE secretion in AMC culture was evaluated by incubating the
culture with 0.1 nM E2 for 0, 0.1, 0.5, 1.0, 4.0, 16.0, 36.0, 48.0 hours. Following
incubation,

the

medium was collected and

secreted apoE was

quantified by

immunoprecipitation followed by immunoblotting. ApoE secretion significantly increased
(p<0.01) after 4 hr, and plateaued after 16 hr incubation (Fig. 4.). These data suggest a
time-dependent increase in apoE secretion as a function of E2 incubation.

3. 5. Effects of £2 on adult mouse cortical neurons from apoE deficient (apoE KO) mice
To examine the impact of apoE deficiency on E2 effects on neurite outgrowth, I
incubated Al\1C neurons from apoE KO and wide type control mice (C57BL/6) with the
physiological concentration (0.1 nM) of E2. Following 3 days of incubation neurite
outgrowth was monitored. Results from this study demonstrated that E2 had no significant
effect on neurite outgrowth from AMC neurons derived from apoE KO mice (Fig. 5).

19

A.

eur&srj•···••rr•·
0.1
pM

0

1.0
pM

1.0
nM

0.1
nM

10
nM

E2

8.

*

14
Gi'12

>

~ 10
Cl>

ix:

c

0
w

8
6

0
c. 4
<(
2

0
Mem

0.1
pM

* p<0.01 Vs Mem

1.0
pM

0.1
nM

1.0
nM

10
nM

E2

Fig.3. Effects of E2 on ApoE Secretion from Adult Mouse
Cortical Neurons. AMC culture from wide type mice was
incubated for 3 days in medium alone or in medium containing
virious concentration of E2. Medium was collectd and ApoE
in 2ml of medium was immunoprecipitated and immunoblotted
as described in methods section. A. Photograph of a
representative immunoblot. B. Densitometric scanning of
immunoblot obtained from three independent experiments. Data
are presented as its mean ± SEM (n=3).

20

A.

0

0.1

0.5

1
4
Hours

36

16

48

8.

-

*

4

*

*

Q)

>

+:;

-

ca 3
Q)

0::

c

-w
0

2

0

a. 1

<(

0

0 0.1 0.5 1.0

4 16 36 48
Hours

*P<0.01 Vs 0 Hour
Fig. 4. Time Course of E2 on ApoE Secretion from AMC
Neurons. AMC culture from wide type mice was incubated
with 0.1 nM E2 for the indicated hours. Following incubation
the medium was collected and apoE in 2ml medium was
immunopricipitaed and immunoblotted as described in
Method section. A. Photograph of a representative
immunoblot. B. Densitometric scanning of immunoblot
obtained from three independent experiments. Data are
presented as its mean ± SEM.

21

lVIedium

Ethanol

~ . ;.

''

·'

•<

:

..

E2

Fig. SA. Effects of E2 on Neurite Outgrowth from ApoE KO
AMC Neurons. Phase contrast photograph of representation
neurons from ApoE KO mice grown for 3 days in medium
alone, in medium containing O.lnM ethanol or O.lnM E2
dissolved ethanol.

22

L_

a.

E

-

::t

c:

·-~0

C1>

50

><
w
C1>

' i::
:::J
C1>

z

25
Mem

Eth

E2

-

E
125
::t

.c:

c,
100
c:
C1>

..J
"C
C1>

75

·-c:

E 50
0

(.)

25
Mem

Eth

E2

Fig. SB. Quantification of the Effects of E2 on Neurite
Extension (a) and Combined Length (b) from apoE KO AMC
Neurons. Neurite extension and combined length for 120
neurons from each group as described under ~Iethod. Data are
mean ±SEM (n=120).

23

l\rledium

Ethanol

;

E2

ApoE2

_ApoE.2 +E2

,
'-.

'l

24

Apo~3

+E2

,...

'

,,_..

..t

.,

'

~

.

: '.

ApoE4 +E2

Fig. 6A. Combined Effects of E2 and Recombinant Human ApoE on
Neurite Outgrowth from ApoE KO AMC Neurons. Phase contrast
photograph of representation neurons from apoE KO mice grown in
3 days in medium alone, in medium containing O.lnM ethanol,
O.lnM E2, 5 µg/ml purified human apoE2, 5 µg/ml purified human
apoE3 and 5 µg/ml purified human apoE4.

25

a.
[////ZJ

-100
E
_,

-

....I...

Mem
+Eth
+E2

c:: 75

**

-~

*

.n

*T

0

**

,-----r

T:

I

t/)

c::

...><
...
Q,)

50

Q,)
Q,)

'i::

25

::I
Q,)

z

0

Control

ApoE2

ApoE3 ApoE4

b.

-...g>

vzzzzi

E 250
::i.

Mem

**

-•+Eth
'------' +E2

**

*

*

.c::

200

*

Q,)

..J

-g
c::

*

150

.c

~

u

100

Control

ApoE2

ApoE3 ApoE4

* P<0.01 Vs Mem
**P<0.01

Fig. 6B. Quantification of the Effects of E2 and Recombinant
Human ApoE on Neurite Extension (a) and Combined Length
(b) from apoE KO AIVIC Neurons. N eurite extension and
combined length for 120 neurons from each group as described
in method. Data are mean ±SEM (n=120).

26

3. 6. Effects of £2 on neurite outgrowth from adult mouse cortical neurons derived from
apoE KO mice in presence of recombinant human apoE isoforms
Previous studies from our laboratory have shown that apoE isoforms can
modulate neurite outgrowth from M1C neurons. In the present study we examined if
apoE isofom1s can alter neurite outgrowth promoting effect of E2. As shown in Fig. 6,
incubation of AMC culture with human apoE2 and apoE3 significantly (p<0.01)
increased both neurite extension and combined length. In contrast to apoE2 and apoE3,
addition of human apoE4 did not essentially affect (p>0.05) neurite outgrowth.
Furthermore, the presence of human apoE2 or apoE3 greatly augmented E2 effects
(p<0.01) on promoting neurite outgrowth, whereas the presence of apoE4 had no
significant effect (p>0.05).
3. 7. Effects of E2 on adult mouse cortical neurons derived from human apoE transgenic

mice
I next examined the effect of E2 on neurite outgrowth from AMC neurons derived
from transgenic mice expressing human apoE3 or human apoE4. Consistent with
previous studies AMC neurons from apoE3 mice grown in medium alone had greater
neurite extension and combined length as compared to those neurons derived from apoE4
transgenic mice (Holtzman et al., 1995). Furthermore, incubation of AMC neurons from
apoE3 transgenic mice with E2 significantly increased neurite outgrowth, whereas
incubation of AMC neurons from apoE4 transgenic mice with E2 had no significant
effect (Fig. 7.).
Western blot analysis of human apoE secretion revealed that both apoE3 and
apoE4 Alv1C cultures secrete similar amounts of apoE. E2 treatment upregulated apoE
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secretion in both apoE3 and apoE4 cultures, similar to that in wild type culture. There was
no significant difference in the amount of apoE secreted by AMC cultures from apoE3 and
apoE4 mice treated with E2 (Fig. 8.).
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·4. Discussion:
E2 replacement therapy appears to delay the onset of Alzheimer's disease, but the
mechanisms for this action are not known. E2 loss is not an issue for males, because they
produce endogenous E2 throughout their lives.

ApoE is of special importance in the

nervous system. ApoE with a source of cholesterol promote marked neurite extension in
cultured dorsal root ganglion cells. ApoE is involved in the response to neural injury
(Boyles et al., 1990; Poirier et al., 1991; Poirier, 1994), maintainance of dendritic
complexes (Masliah et al., 1995) and neuronal remodeling in vitro (Nathan et al., 1994;
Fafan et al., 1996) and in AD (Arendt et al., 1997).
Previous studies have demonstrated an apoE isoform-specific effect on neurite
outgrowth from both central nervous system- (Neuro-2a cells and GT2 trk 9 cells) and
peripheral nervous system- (dorsal root ganglion cells) derived neurons (Nathan et al.,
1994; Bellosta et al., 1995; Holtzman et al., 1995; Nathan et al., 1995). In the presence of
lipoprotein, apoE3 enhances neurite outgrowth, whereas apoE4 inhibits neurites
I

outgrowth. Our laboratory has previously shown that apoE4 inhibits and apoE3 promotes
neurite outgrowth in cultured AMC neurons through the low-density lipoprotein receptorrelated protein pathway (Nathan et al., 2002). It is now recognized that apoE2 and E3
gene is relatively protective against sporadic AD, while apoE4 gene increases severalfold the chances of developing the disease (Sapolsky, et al., 2000). The recent data also
suggest the apparent greater risk of AD in female carriers of e4 than in males (Poirier et
al., 1993; Payami et al., 1996; Rao et al., 1996). This could be attributed to an E2
deficient state combined with the e4 genotype to diminish neuronal plasticity.
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Because apoE mRNA levels in the brain are induced by E2 (Srivastava et al.,
1996; Stone et al., 1997), I hypothesize that E2 will support neurite outgrowth in M1C
culture via increased apoE production. Consistent with this hypothesis, results from this
study have suggested that E2 increases apoE secretion from AMC neurons derived from
wild type mice in a dose dependent manner. Furthermore, E2 promotes neurite outgrowth
from AMC neurons in a dose dependent fashion. Further support for the role of apoE in
mediating E2 effects on neurite outgrowth comes from my studies on apoE KO mice. E2
has no significant effect on neurite outgrowth from AMC neurons derived from apoE KO
mice, suggesting that apoE plays a vital role in mediating the effect of E2 on neurite
outgrowth.
In this study by using two different model systems I have shown that E2 has

isoform specific effects on neurite outgrowth in the presence of human apoE. Results
from my recombinant apoE experiments clearly demonstrate that E2 could greatly
promote neurite outgrowth in the presence of apoE2 or apoE3, but has no effect in the
presence of apoE4, the isoform implicated in AD. These results are consistent with my
studies using transgenic mice. E2 increased neurite outgrowth in AMC neurons derived
from apoE3 mice, but not in apoE4 mice. How apoE isoforms modulate E2 effects on
neurite outgrowth is not clear from this study.
Based on my results, I have developed a model that might help to explain the
potential role of E2 and apoE in the pathogenesis of AD. The model proposes that AD is
an imbalance between neuronal injury and efficient repair. In this model, neurons that are
debilitated by age are more susceptible to neurotoxic agents (e.g., amyloid peptide, and
free radicals). The damage inflicted by these injurious agents signal the need for repair or
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remodeling of the neurons and neurites. At this stage, the presence of E2 will maintain
the secretion of apoE in the brain. If apoE2 or apoE3 is the isofom1 of apoE produced in
the brain then they may support the repair processes. In contrast if apoE4 is produced in
the brain it may not support repair very well and thus may contribute to the onset of AD.
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